About 40% of EGPA patients have perinuclear ANCA antibodies against myeloperoxidase (MPO), resulting in the classification of EGPA as an ANCA-associated vasculitis (192, 193). The gene discussed is MPO; the disease is eosinophilic granulomatosis with polyangiitis.